ES2428387T3 - Prostamidas donadoras de óxido nítrico - Google Patents

Prostamidas donadoras de óxido nítrico Download PDF

Info

Publication number
ES2428387T3
ES2428387T3 ES09742454T ES09742454T ES2428387T3 ES 2428387 T3 ES2428387 T3 ES 2428387T3 ES 09742454 T ES09742454 T ES 09742454T ES 09742454 T ES09742454 T ES 09742454T ES 2428387 T3 ES2428387 T3 ES 2428387T3
Authority
ES
Spain
Prior art keywords
ono2
independently selected
alkynyl
cycloalkoxy
alkoxyalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09742454T
Other languages
English (en)
Spanish (es)
Inventor
Francesca Benedini
Stefano Biondi
Valerio Chiroli
Wesley Kwan Mung Chong
Liming Dong
Achim Hans-Pter Krauss
Fabio Nicoli
Ganesh Prasanna
William Francois Vernier
Yi Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicox SA
Original Assignee
Nicox SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox SA filed Critical Nicox SA
Application granted granted Critical
Publication of ES2428387T3 publication Critical patent/ES2428387T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES09742454T 2008-05-09 2009-05-11 Prostamidas donadoras de óxido nítrico Active ES2428387T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5208408P 2008-05-09 2008-05-09
US52084P 2008-05-09
US13933308P 2008-12-19 2008-12-19
US139333P 2008-12-19
PCT/IB2009/005594 WO2009136281A1 (en) 2008-05-09 2009-05-11 Nitric oxide donating prostamides

Publications (1)

Publication Number Publication Date
ES2428387T3 true ES2428387T3 (es) 2013-11-07

Family

ID=41020929

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09742454T Active ES2428387T3 (es) 2008-05-09 2009-05-11 Prostamidas donadoras de óxido nítrico

Country Status (8)

Country Link
US (1) US8101658B2 (enExample)
EP (1) EP2274279B1 (enExample)
JP (1) JP5401540B2 (enExample)
CN (1) CN102099330B (enExample)
AR (1) AR076731A1 (enExample)
CA (1) CA2723704C (enExample)
ES (1) ES2428387T3 (enExample)
WO (1) WO2009136281A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8519178B2 (en) 2009-06-22 2013-08-27 Johnson Matthey Public Limited Company Method for the purification of prostaglandins
JP5885271B2 (ja) * 2011-02-14 2016-03-15 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ ビマトプロストのエステル誘導体の組成物および方法
WO2013132497A1 (en) 2012-03-07 2013-09-12 Advanced Inhilation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
CA2871292A1 (en) 2012-05-31 2013-12-05 Theravance Biopharma R&D Ip, Llc Nitric oxide donor neprilysin inhibitors
US10047047B2 (en) 2015-03-31 2018-08-14 Nicox S.A. Nitric oxide donating derivatives of latanoprost free acid
WO2016155906A1 (en) 2015-03-31 2016-10-06 Nicox S.A. Nitric oxide donating derivatives of fluprostenol
EP3088388A1 (en) 2015-04-30 2016-11-02 NicOx S.A. Nitric oxide donating derivatives of prostaglandins
EP4548975A3 (en) 2015-09-09 2025-07-23 Beyond Air Ltd Nitric oxide inhalation therapy for infants with bronchiolitis
JP7055802B2 (ja) 2016-11-08 2022-04-18 ボシュ・アンド・ロム・インコーポレイテッド 正常眼圧緑内障を処置するための一酸化窒素放出プロスタグランジン誘導体
EP3757089B1 (en) * 2018-02-21 2022-05-11 Nicox S.A. Process for the preparation of a nitric oxide donating prostaglandin analogue
RU2718744C2 (ru) 2018-05-17 2020-04-14 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные простагландина F2альфа для снижения внутриглазного давления
CA3105989A1 (en) * 2018-07-12 2020-01-16 Nicox S.A. Ophthalmic compositions containing a nitric oxide releasing prostamide
HUE064405T2 (hu) * 2019-08-05 2024-03-28 Nicox Sa Eljárás nitrogén-oxid donor prosztaglandin analóg elõállítására
ES3017242T3 (en) * 2021-02-03 2025-05-12 Nicox Sa Process for the preparation of a nitric oxide donating prostaglandin analogue
CN117979973A (zh) 2021-09-20 2024-05-03 尼科斯股份有限公司 作为神经保护剂的释放一氧化氮的前列腺酰胺
CN113943266A (zh) * 2021-11-18 2022-01-18 广州楷石医药有限公司 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途
MA71652A (fr) 2022-07-07 2025-05-30 Nicox S.A. Procédé industriel pour la préparation d'acide hexanoique, 6-(nitrooxy)-, (1s,2e)-3-(1r,2r,3s,5r)-2- (2z)-7-(éthylamino)-7-oxo-2-hepten-1-yl)
CN115677549A (zh) * 2022-10-27 2023-02-03 神隆医药（常熟）有限公司 一种贝美前列素手性异构体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6395787B1 (en) * 2000-02-08 2002-05-28 Allergan Sales, Inc. Ocular hypotensive lipids
TWI298257B (en) * 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
JP2005519115A (ja) * 2002-03-01 2005-06-30 アラーガン、インコーポレイテッド プロスタミドの製造
EP1704141B1 (en) * 2004-01-05 2016-02-24 Nicox S.A. Prostaglandin nitrooxyderivatives
WO2007000641A2 (en) * 2005-06-29 2007-01-04 Pfizer Inc. Prostaglandin derivatives
US20070015838A1 (en) * 2005-07-14 2007-01-18 Allergan, Inc. Cyclopentane n-lower alkyl heptenamide-5-cis-2-(3alpha-hydroxy-5-phenylpentyl)-3, 5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
US20110092590A1 (en) 2011-04-21
EP2274279A1 (en) 2011-01-19
JP2011519910A (ja) 2011-07-14
CA2723704C (en) 2017-08-22
CN102099330A (zh) 2011-06-15
CA2723704A1 (en) 2009-11-12
WO2009136281A1 (en) 2009-11-12
CN102099330B (zh) 2014-04-30
JP5401540B2 (ja) 2014-01-29
US8101658B2 (en) 2012-01-24
HK1160835A1 (en) 2012-08-17
AR076731A1 (es) 2011-07-06
EP2274279B1 (en) 2013-07-31

Similar Documents

Publication Publication Date Title
EP2274279B1 (en) Nitric oxide donating prostamides
CN102378762B (zh) 丙型肝炎病毒抑制剂
TWI501957B (zh) Ｃ型肝炎病毒抑制劑
ES2566800T3 (es) Nitrooxiderivados de prostaglandinas
CA3103711A1 (en) Spirocyclic indane analogues as il-17 modulators
TWI438200B (zh) Ｃ型肝炎病毒抑制劑
KR101982912B1 (ko) 융합된 헤테로사이클릭 화합물, 이의 제조 방법, 약학적 조성물, 및 그 용도
JP2020523418A (ja) Ｉｌ−１７調節剤としてのスピロ環インドリン
JP2024525044A (ja) Ｉｌ－１７モジュレータとしてのイミダゾトリアジン誘導体
US20230271973A1 (en) Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists
CN103827108B (zh) 丙型肝炎病毒抑制剂
CA3110767A1 (en) Benzimidazolone derivatives, and analogues thereof, as il-17 modulators
WO2021170627A1 (en) Difluorocyclohexyl derivatives as il-17 modulators
EP4259631A1 (en) Imidazopyridazine derivatives as il-17 modulators
WO2021170631A1 (en) Difluorocyclohexyl derivatives as il-17 modulators
WO2021204800A1 (en) Difluorocyclohexyl derivatives as il-17 modulators
ES2619708T3 (es) Inhibidores de la replicación del virus de inmunodeficiencia humana
EP4132650A1 (en) Difluorocyclohexyl derivatives as il-17 modulators
WO2019205979A1 (zh) 非天然氨基酸类衍生物、包含其的药物组合物及其制备方法和用途
CA3259558A1 (en) COMPOUNDS FOR THE TREATMENT OF CORONAVIRUS INFECTION
EP0518672A2 (en) Cyclic renin inhibitors
TW201416363A (zh) Ｃ型肝炎病毒抑制劑
EP0518676A2 (en) Cyclic renin inhibitors
HK1160835B (en) Nitric oxide donating prostamides
CN116440127A (zh) 一种多肽衍生物及其抗病毒用途